Incidence of SICH after thrombectomy is higher in Asian patients with acute ischemic stroke. Cardioembolic stroke, poor collateral circulation, delayed endovascular treatment, multiple passes with stent retriever device, lower pretreatment Alberta Stroke Program Early Computed Tomography Score, higher baseline neutrophil ratio may increase the risk of SICH.
Purpose
The aim of this study was to investigate the relationship between obesity and cognitive impairment in the Chinese elderly.
Patients and methods
Patients aged 60 years or above were enrolled from the Department of Geriatrics of The First Affiliated Hospital of Chongqing Medical University from March 2013 to May 2017. Mini-Mental State Examination scale was used to assess the cognitive function. Body mass index (BMI) and waist–hip ratio were used to classify obesity. Student’s
t
-test, Mann–Whitney
U
-test, or chi-squared test was used to compare the data between participants with normal cognition and participants with cognitive impairment as appropriate. Univariate logistic regression models and multivariate logistic regression models were performed to explore the relationship between BMI or abdominal obesity and cognitive impairment.
Results
A total of 1,100 patients including 568 men and 532 women aged 60–98 years (median age 79 years) were enrolled. After adjusting for age, gender, smoking, drinking, education level, hypercholesterolemia, hypertension, and diabetes, overweight was significantly associated with a decreased risk of cognitive impairment (OR=0.458, 95% CI=0.298–0.703,
P
<0.001). After adjustment for age, education level, hypercholesterolemia, hypertension, and diabetes, abdominal obesity remained significantly associated with an increased risk of cognitive impairment (OR=1.532, 95% CI=1.037–2.263,
P
=0.032).
Conclusion
Overweight is associated with a decreased risk of cognitive impairment in the Chinese elderly, while abdominal obesity is associated with an increased risk of cognitive impairment independent of conventional sociodemographic, lifestyle, and health-related comorbid factors.
Superior catalytic activity and high chemical stability of inexpensive electrocatalysts for the oxygen reduction reaction (ORR) are crucial to the large-scale practical application of fuel cells. The nonprecious metal/N modified graphene electrocatalysts are regarded as one of potential candidates, and the further enhancement of their catalytic activity depends on improving active reaction sites at not only graphene edges but also its basal plane. Herein, the ORR mechanism and reaction pathways of Co-N co-doping onto the graphene basal plane have been studied by using first-principles calculations and ab initio molecular dynamics simulations. Compared to singly N-doped and Co-doped graphenes, the Co-N co-doped graphene surface exhibits superior ORR activity and the selectivity toward a four-electron reduction pathway. The result originates from catalytic sites of the graphene surface being modified by the hybridization between Co 3d states and N 2p states, resulting in the catalyst with a moderate binding ability to oxygenated intermediates. Hence, introducing the Co-N4 complex onto the graphene basal plane facilitates the activation of O2 dissociation and the desorption of H2O during the ORR, which is responsible for the electrocatalyst with a smaller ORR overpotential (∼1.0 eV) that is lower than that of Co-doped graphene by 0.93 eV. Our results suggest that the Co-N co-doped graphene is able to compete against platinum-based electrocatalysts, and the greater efficient electrocatalysts can be realized by carefully optimizing the coupling between transition metal and nonmetallic dopants in the graphene basal plane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.